Press releases
Access archived Guidant press releases
Access archived BTG press releases
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Mar 5, 2018
Boston Scientific Corporation (NYSE: BSX) will participate in the Barclays Global Healthcare Conference on March 13 in Miami Beach, Florida. Dan Brennan, executive vice president and chief...
-
Mar 5, 2018Acquisition expands endoscopic portfolio to include radiofrequency devices
Boston Scientific (NYSE: BSX) today announced that it has acquired EMcision, Limited, a privately held company located in the United Kingdom and Canada. The acquisition will expand the Boston...
-
Feb 26, 2018
Boston Scientific Corporation (NYSE: BSX) completed a public offering of $1.0 billion aggregate principal amount of its 4.000% senior notes due March 1, 2028. The Company previously announced that...
-
Feb 22, 2018
Boston Scientific Corporation (NYSE: BSX) announced the pricing of a public offering of $1.0 billion aggregate principal amount of its 4.000% senior notes due March 1, 2028 under the company's...
-
Feb 1, 2018
Boston Scientific Corporation (NYSE: BSX) generated sales of $2.408 billion during the fourth quarter ended December 31, 2017. This represents growth of 9.9 percent on a reported basis and 8.1...
-
Jan 29, 2018
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the LEERINK Partners 7th Annual Global Healthcare Conference on February 15, 2018 in New York. Dan Brennan, executive vice...
-
Jan 24, 2018
Boston Scientific commends the efforts of key champions in the U.S. House and Senate for their successful efforts to suspend the medical device tax, allowing the device industry to reinvest in...
-
Jan 24, 2018Millipede, Inc. is developing the IRIS Transcatheter Annuloplasty Ring System to treat severe mitral regurgitation
Boston Scientific Corporation (NYSE: BSX) today announced it has closed an investment and entered into an acquisition option agreement with Millipede, Inc., a privately-held company that has...
-
Jan 19, 2018
Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results and business highlights for the fourth quarter ended December 31, 2017 on Thursday, February...
-
Jan 12, 2018Randomized controlled trial demonstrates effectiveness of long-term treatment with sub-perception spinal cord stimulation
Boston Scientific Corporation (NYSE: BSX) today announced positive results from the WHISPER randomized controlled trial (RCT). The data, presented at the 2018 Annual Meeting of the North American...
-
Jan 11, 2018System offers non-opioid treatment option with multiple therapies for people with chronic pain
Boston Scientific Corporation (NYSE: BSX) today announced that the U.S. Food and Drug Administration (FDA) has approved the Spectra WaveWriter™ Spinal Cord Stimulator (SCS) System. It is the...
-
Jan 9, 2018
Boston Scientific Corporation (NYSE: BSX) generated sales, based upon preliminary unaudited financial information, of approximately $2.41 billion during the fourth quarter ended December 31, 2017....